Split Dose ATG Strategy Prevents Grade III-IV Acute GVHD and is Associated with Immune Surrogates of GVL
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Highlights into historical and current immune interventions for cancer.
Cole K, Al-Kadhimi Z, Talmadge J Int Immunopharmacol. 2023; 117:109882.
PMID: 36848790 PMC: 10355273. DOI: 10.1016/j.intimp.2023.109882.